Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Wim H.J. Kruit, Ulrich Keilholz, Frédéric Lehmann et al.|Journal of Clinical Oncology|2013

Cited by 222